期刊文献+

自体外周血造血干细胞移植治疗难治性系统性红斑狼疮 被引量:2

Autologous Peripheral Blood Stem Cell Transplantation for Treatment of Refractory Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的:探讨自体外周血造血干细胞移植(APBSCT)治疗难治性系统性红斑狼疮(SLE)的临床疗效。方法:用APBSCT治疗4例难治性SLE。干细胞动员应用环磷酰胺(CTX)4g/m^2,分两天应用和粒细胞集落刺激因子(GCSF)5~10μg/kg·d^-1;预处理方案包括CTX(50mg/kg·d^-1,-6、-5、-4、-3d),抗胸腺细胞球蛋白(ATG15~20mg/kg·d^-1,-2、-1、+1、+2d)。结果:4例患者均获得造血重建,中性粒细胞〉0.5×10^9/L,血小板〉20×10^9/L的中住数时间分别是9d,10d;SLE的临床表现明显减轻,尿蛋白减少或消失,自身抗体转阴或滴度减低,泼尼松用量〈10mg/d;无移植相关死亡。结论:APBSCT治疗难治性SLE近期疗效显著,造血重建恢复迅速,安全有效,远期疗效尚需进一步观察。 Objective: To investigate the efficacy of autologous peripheral blood stem cell transplantation (APBSCT) in treatment of refractory systemic lupus erythematosus (SLE). Methods. Four patients with refractory SLE received APBSCT. Peripheral stem cells were mobilised with CTX (4g/m^2) and G-CSF (5-10μ/kg·d^-1 ). Preparative regimen consisted of CTX (50 rng/kg·d^-1 , - 6d, - 5d, - 4d, - 3d) plus antithymocyte globulin(ATG 15-20 mg/kg·d^-1 , - 2d, - 1d, + 1d, + 2d). Results: The hematopioetic reconstitution of the 4 patients was successful after APBSCT. The median time for granulocyte count 〉0. 5 × 10^9 / L was 9 days, and for plateht 〉20×10^9/L was 10 days. The clinical manifestations of the patients improved obviously after transplantation. The proteinuria decreased or disappeared, and the autoantibodies decreased or became negative. The dosage of prednisone was less than 10 mg/d. There was no transplantation related mortality. Conclusion: APBSCT for refractory SLE shows remarkabh short-term effecL Hematopoietic reconstitution soon recover. It is safe and effective, but the long-term effects have to be observed.
出处 《内科急危重症杂志》 2006年第4期167-169,共3页 Journal of Critical Care In Internal Medicine
关键词 系统性红斑狼疮 造血干细胞移植 Systemic lupus erythematosus Hematopoietic stem cell transplantation
  • 相关文献

参考文献2

二级参考文献12

  • 1Oyama Y, Traynor AE, Craig R, et al. Treatment related mortality (TRM) and overall mortality (OM) in patients underging autologous hematopoietic atem cell trasplantation (HSCT) for autoimmune diseases, a single center experience. Blood, 2003, 102: 986. 被引量:1
  • 2Lisukov IA, Sizikova SA, Kulagin AD, et al. High-dose immunosuppression with autologus stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus, 2004, 3: 89-94. 被引量:1
  • 3McSweeney PA. Hematopoietic stem cell transplantation for severe autoimmune diseases. American Society of Hematology Educational Program Book. San Diego, 2003. 379-387. 被引量:1
  • 4Burt RK, Traynor A. Hematopoietic stem cell therapy of autoimmune diseases. Curr Opin Hematol, 1998, 5: 472-477. 被引量:1
  • 5Traynor A, Barr WG, Rosa RM, et al. Hematopoietic stem cell transplantation for severe and refractory lupus: analysis after five years and fifteen patients. Arthritis Rheum, 2002, 46: 17-23. 被引量:1
  • 6Austin HA, Klippel JH, Balow JE, et al. Therapy of nephritis:controlled trial of prednisone and cytotoxic drugs. New Engl J Med, 1986, 314: 614-619. 被引量:1
  • 7Snowden JA. Haematopoietic stem cell transplantation in autoimmune and inflammatory diseases. CPD Haematology, 2003, 4:12-16. 被引量:1
  • 8Burt RK, Fassas A, Snowden J, et al. Collection of hematopoietic stem cell from patients with autoimmune diseases. Bone Marrow Transplant, 2001, 28: 1-12. 被引量:1
  • 9Burt RK, Marmont A, Arnold R, et al. Development of a phase Ⅲtrial of hematopoietic stem cell transplantation for systemic lupus erythematosus. Bone Marrow Transplant, 2003, 32:49-51. 被引量:1
  • 10孙凌云,欧阳健,张杏书.造血干细胞移植治疗自身免疫病[J].中华风湿病学杂志,1998,2(2):111-113. 被引量:8

共引文献11

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部